In the medical field, transparency and access to information are essential. However, the recent decision by the New England Journal of Medicine to cut off certain publications from advanced access to its embargoed journal articles raises concerns. As pointed out by Ivan Oransky, MD, this move resembles a “don’t ask, don’t tell” policy, which could
Health
In today’s society, where bad news seems to dominate the media landscape, important trends often get overshadowed by the constant influx of negative content. One such trend is the increasing incidence of abuse and neglect towards dependent individuals, such as children, the elderly, or those with disabilities. Neglecting the care of a dependent person can
Recently, the New England Journal of Medicine (NEJM) made the decision to limit access to its embargoed journal articles for certain publications. Dawn Peters, the director of strategic communications & media relations at NEJM Group, stated in an email to MedPage Today that news outlets catering to physician readers will no longer meet the criteria
A groundbreaking treatment option for amyotrophic lateral sclerosis (ALS) has shown positive results in the phase IIb PARADIGM trial. Developed by NeuroSense Therapeutics, PrimeC is a unique formulation containing ciprofloxacin and celecoxib, both of which are FDA-approved drugs. The results of this trial were presented by Merit Cudkowicz, MD, MSc from Massachusetts General Hospital at
The use of antipsychotics in dementia patients has been associated with an increased risk for a wider range of adverse outcomes than previously acknowledged. A population-based matched cohort study from the U.K. revealed that dementia patients prescribed antipsychotics were more than twice as likely to be diagnosed with pneumonia within 90 days compared to non-users.
The results from the open-label, phase II Galactic53 trial on Viltolarsen (Viltepso) presented at the American Academy of Neurology annual meeting showed promising outcomes for boys and men with Duchenne muscular dystrophy (DMD). The study indicated that Viltolarsen was well tolerated with no new safety concerns. Moreover, there was a potential clinical benefit in pulmonary
The recent conviction of Dallas anesthesiologist Raynaldo Rivera Ortiz Jr., MD, for injecting a nerve-blocking agent and other drugs into IV bags resulting in a coworker’s death and multiple cardiac emergencies among patients is a haunting reminder of the dangers of medical malpractice. Such negligence not only puts lives at risk but also erodes public
Despite advancements in access to newer cholesterol-lowering drugs, such as highly effective medications, the frustration surrounding the prior authorization process persists. Physicians like Christie Ballantyne, MD, from Baylor College of Medicine, express the sentiment that dealing with the bureaucratic hurdles of prior authorization remains a significant obstacle in providing optimal care for patients. This highlights
A 28-year-old woman presented with a gradually expanding mass in the inside corner of her left eye, leaving doctors puzzled at the cause behind this unusual development. This case, reported in JAMA Ophthalmology by Grégoire Van Acker, MD, and his team at Cliniques Universitaires Saint-Luc in Brussels, sheds light on a rare ocular infection linked
During a recent hearing of the House Committee on Oversight and Accountability, Republican lawmakers did not hold back in their criticism of FDA Commissioner Robert Califf, MD. Committee Chair Rep. James Comer (R-Ky.) kicked off the proceedings by accusing the FDA under President Biden of dysfunction and not fulfilling its responsibility to ensure the safety